Haemonetics to Acquire Cardiva Medical for ~$510M

Shots: Cardiva to receive $475M up front and up to an additional ~$35M in contingent consideration based on sales growth. The transaction is expected to be completed in Q1’21 The acquisition expands Haemonetics’ blood transfusion and loss management offerings and enhance its penetration into the large and growing interventional cardiology and electrophysiology markets Cardiva’s portfolio …

Haemonetics to Acquire Cardiva Medical for ~$510M Read More »